Emer Cooke, EMA executive director (Tomas Tkacik/Sipa USA/Sipa via AP Images)

EMA chief tells Eu­ro­pean Par­lia­ment it's no longer in cri­sis mode on pan­dem­ic, ready to han­dle short­ages

The Eu­ro­pean Med­i­cines Agency said it’s no longer in cri­sis mode as pan­dem­ic-re­lat­ed ac­tiv­i­ties ta­per off, and the agency is more co­or­di­nat­ed than ever be­fore and ready for new drug short­ages that come this win­ter.

Emer Cooke, ex­ec­u­tive di­rec­tor of the EMA, on Mon­day told the Eu­ro­pean Par­lia­ment’s Com­mit­tee on En­vi­ron­ment, Pub­lic Health and Food Safe­ty that there’s been a no­table in­crease in the agency’s busi­ness ac­tiv­i­ties in 2023, in­clud­ing the fact that biosim­i­lar ap­pli­ca­tions have more than dou­bled when com­pared to last year. Sev­er­al mem­bers of Par­lia­ment ques­tioned Cooke about dif­fer­ent de­vel­op­ments, in­clud­ing phar­ma-re­lat­ed leg­is­la­tion pro­posed in the spring that will like­ly in­clude new reg­u­la­to­ry re­forms.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.